Report Code : CVMI2501165 | Published Date : March 3, 2025
Market Overview:
The neurorehabilitation devices market encompasses robotic exoskeletons, brain-computer interfaces (BCIs), non-invasive stimulators, and virtual reality (VR) systems designed to restore motor and cognitive function in patients with stroke, spinal cord injuries, Parkinson’s disease, and multiple sclerosis. This market is driven by the increasing prevalence of neurological disorders, aging populations, and technological advancements, moving towards home-based, AI-driven rehabilitation.
Market Size and Forecast
Year |
Market Value (USD Billion) |
Notes |
2023 |
2.1 |
Dominated by robotic gait trainers (45% share). |
2028 |
5.8 |
CAGR 22.5% (2023–2028); VR/BCI adoption soars. |
2035 |
14.3 |
CAGR 18.7% (2028–2035); home-use devices claim 40% share. |
1.2 million+ devices in use by 2035, with 60% deployed in post-stroke rehab.
Market Drivers
- Neurological Epidemic: Stroke Cases Set to Rise by 34% Globally (2023–2035).
- Home healthcare trend: 50% of patients prefer telerehabilitation post-COVID.
- AI/ML integration: Devices like Rewalk Robotics’ exoskeletons adapt to patient progress in real-time.
- Government funding: NIH allocates USD 500M/year for neurotech R&D.
Market Challenges
- High costs: Exoskeletons typically average between USD 70,000 and 150,000.
- Reimbursement gaps: Only 25% of insurers cover home-based neuro rehab.
- Clinical validation: BCIs require 5–7 years of trials for FDA approval.
Competitive Landscape
Company |
2023 Share |
Core Strengths |
Recent Moves |
Hocoma (DKSH) |
30% |
Robotic gait trainers |
Launched AI-powered Lokomat (2024). |
Ekso Bionics |
20% |
Exoskeletons for stroke |
Won USD 40M DoD contract (2025). |
Neuroelectrics |
15% |
Non-invasive tDCS/tACS |
FDA-cleared Starstim for home use (2025). |
Startups (e.g., MindMaze) |
35% |
VR neurorehab |
Raised USD 200M for PTSD therapy (2024). |
Market Segmentation
Segment |
2023 Share |
CAGR (2023–2035) |
By Product |
||
Robotic Systems |
45% |
20.1% |
BCIs |
15% |
28.5% |
By End User |
||
Hospitals |
50% |
17.8% |
Home Care |
30% |
25.4% |
Regional Analysis
- North America (XX%): The U.S. leads with Medicare coverage for robotic rehabilitation.
- Europe (35%): Germany’s universal healthcare drives adoption.
- Asia-Pacific (XX%): Japan invests in stroke rehab centers.
Technology & Innovation
- Hybrid exoskeletons: Combine robotics + functional electrical stimulation (FES).
- Cloud-based rehab: Therapists monitor patients remotely via AI dashboards.
- Gamified VR: MindMaze’s VR games improve compliance in pediatric rehab.
Regulatory Environment
- FDA: Expedited pathway for breakthrough neurodevices.
- EU MDR: Class III certification required for invasive BCIs.
Strategic Outlook
- Providers: Partner with insurers to expand reimbursement.
- OEMs: Focus on modular, affordable home devices.
Reasons To Buy

Scope

Key Players
- Hocoma AG
- Bionik Laboratories Corp.
- Abbott Laboratories
- Ectron Ltd.
- Ekso Bionics Holdings, Inc.
- Medtronic plc
- Bioventus LLC
- Bioness Inc.
- BioXtreme Robotics Rehabilitation
- Neuro Rehab VR
- Tyromotion GmbH
- Kinova Inc.
- Saebo, Inc.
- ReWalk Robotics Ltd.
- Helius Medical Technologies
Neurorehabilitation Devices Market Report
- 1. Neurorehabilitation Devices Market Research Report
- 1.1 Study Objectives
- 1.2 Neurorehabilitation Devices Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2. Neurorehabilitation Devices Market Research Report - Preface
- 2.1 Neurorehabilitation Devices Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Product
- 2.1.2 By End User
- 2.1.3 By Region
- 2.1 Neurorehabilitation Devices Market Research Report – Detailed Scope and Definitions
- 3. Neurorehabilitation Devices Market Dynamics
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Product, By End User, By Country
- 3.3. Opportunities – By Product, By End User, By Country
- 3.4. Trends – By Product, By End User, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Neurorehabilitation Devices Market Research Report – DROTs Impact Analysis
-
- 4. Neurorehabilitation Devices Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5. Neurorehabilitation Devices Market, By Product, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 5.1 Robotic Systems
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 BCIs
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Hospitals
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Home Care
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7. Neurorehabilitation Devices Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
- 7.1 North America
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 North America
- 8. North America Neurorehabilitation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 8.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 8.1.1 Robotic Systems
- 8.1.2 BCIs
- 8.2.1 Hospitals
- 8.2.2 Home Care
- 8.3.1 United States
- 8.3.2 Canada
- 8.4 North America Neurorehabilitation Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2031
- 8.5 Regional Trends Analysis
- 8.6 North America Neurorehabilitation Devices Market Research Report - Company Profiles
- 8.6.1 Company 1 (United States)
- 8.6.2 Company 2 (Canada)
- 8.6.3 Company 3 (Canada)
- 9.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Robotic Systems
- 9.1.2 BCIs
- 9.2.1 Hospitals
- 9.2.2 Home Care
- 9.3.1 Germany
- 9.3.2 United Kingdom
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Russia
- 9.4 Europe Neurorehabilitation Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2031
- 9.5 Regional Trends Analysis
- 9.6 Europe Neurorehabilitation Devices Market Research Report - Company Profiles
- 9.6.1 Company 1 (Germany)
- 9.6.2 Company 2 (United Kingdom)
- 9.6.3 Company 3 (United Kingdom)
- 10.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Robotic Systems
- 10.1.2 BCIs
- 10.2.1 Hospitals
- 10.2.2 Home Care
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia & New Zealand
- 10.3.6 ASEAN
- 10.4 Asia-Pacific Neurorehabilitation Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2031
- 10.5 Regional Trends Analysis
- 10.6 Asia-Pacific Neurorehabilitation Devices Market Research Report - Company Profiles
- 10.6.1 Company 1 (China)
- 10.6.2 Company 2 (Japan)
- 10.6.3 Company 3 (Japan)
- 11.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Robotic Systems
- 11.1.2 BCIs
- 11.2.1 Hospitals
- 11.2.2 Home Care
- 11.3.1 Brazil
- 11.3.2 Mexico
- 11.3.3 Argentina
- 11.3.4 Peru
- 11.3.5 Colombia
- 11.3.6 Rest of Latin America
- 11.4 Latin America Neurorehabilitation Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2031
- 11.5 Regional Trends Analysis
- 11.6 Latin America Neurorehabilitation Devices Market Research Report - Company Profiles
- 11.6.1 Company 1 (Brazil)
- 11.6.2 Company 2 (Mexico)
- 11.6.3 Company 3 (Mexico)
- 12.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Robotic Systems
- 12.1.2 BCIs
- 12.2.1 Hospitals
- 12.2.2 Home Care
- 12.3.1 Saudi Arabia
- 12.3.2 UAE
- 12.3.3 South Africa
- 12.3.4 Egypt
- 12.3.5 Israel
- 12.3.6 Rest of Middle East and Africa
- 12.4 Middle East and Africa Neurorehabilitation Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2031
- 12.5 Regional Trends Analysis
- 12.6 Middle East and Africa Neurorehabilitation Devices Market Research Report - Company Profiles
- 12.6.1 Company 1 (Saudi Arabia)
- 12.6.2 Company 2 (UAE)
- 12.6.3 Company 3 (UAE)
- 13.1 Strategic Dashboard of Top Market Players
- 13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
- 13.2.1 Hocoma AG
- 13.2.2 Bionik Laboratories Corp.
- 13.2.3 Abbott Laboratories
- 13.2.4 Ectron Ltd.
- 13.2.5 Ekso Bionics Holdings Inc.
- 13.2.6 Medtronic plc
- 13.2.7 Bioventus LLC
- 13.2.8 Bioness Inc.
- 13.2.9 BioXtreme Robotics Rehabilitation
- 13.2.10 Neuro Rehab VR
- 13.2.11 Tyromotion GmbH
- 13.2.12 Kinova Inc.
- 13.2.13 Saebo Inc.
- 13.2.14 ReWalk Robotics Ltd.
- 13.2.15 Helius Medical Technologies.
- 8.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 14. Data Collection Method and Research Approach
- 15. Principal Presumptions and Acronyms